The European Society for Blood and Marrow Transplantation (EBMT) 2022

Hemoglobin, Lactate Dehydrogenase, and FACIT-Fatigue Normalization Rates in Patients Treated with Pegcetacoplan: Results from the PEGASUS and PRINCE Phase 3 Clinical Trials

Access Resources

Pegcetacoplan Treatment in Patients with Paroxysmal Nocturnal Hemoglobinuria and Baseline Hemoglobin Levels at or above 10 Grams per Deciliter: A Post Hoc Analysis

Access Resources

Pegcetacoplan Treatment Meaningfully Improves Quality Of Life And Fatigue In Patients With Paroxysmal Nocturnal Hemoglobinuria: Results From Two Phase 3 Clinical Trials

Access Resources

Back to Conference Resources

PNH Congress Presentations

The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.

The European Society for Blood and Marrow Transplantation (EBMT) 2022

Back to Conference Resources

Report an Adverse Event or Product complaint

Ask a Medical Question

Connect with an MSL

Landing